Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading:A multicenter retrospective studyOACSTPCDMEDLINE
Background:The incidence of well-differentiated gastric neuroendocrine tumors(G-NET)is increasing annually,and while they have a good prognosis and low mortality rate,their high recurrence rate makes treatment options controv…查看全部>>
Ju Huang;Huimin Liu;Dekun Yang;Tianming Xu;Jing Wang;Jingnan Li
Department of Gastroenterology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100730,China Key Laboratory of Gut Microbiota Translational Medicine Research,Chinese Academy of Medical Sciences,Beijing 100730,ChinaDepartment of Gastroenterology,Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College,Yantai,Shandong 264000,ChinaDepartment of Gastroenterology,Beijing Zhong-Neng-Jian Hospital,Beijing 102401,ChinaDepartment of Gastroenterology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100730,China Key Laboratory of Gut Microbiota Translational Medicine Research,Chinese Academy of Medical Sciences,Beijing 100730,ChinaDepartment of Gastroenterology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100730,China Key Laboratory of Gut Microbiota Translational Medicine Research,Chinese Academy of Medical Sciences,Beijing 100730,ChinaDepartment of Gastroenterology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100730,China Key Laboratory of Gut Microbiota Translational Medicine Research,Chinese Academy of Medical Sciences,Beijing 100730,China
临床医学
Well-differentiated G-NETSerum gastrinPersonalized treatmentEndoscopic submucosal dissectionEndoscopic mucosal resectionSomatostatin analog therapySurgical resectionRecurrence
《Chinese Medical Journal》 2024 (6)
P.720-728,9
supported by grants from National High-Level Hospital Clinical Research Funding(No.2022-PUMCH-C-055)National High-Level Hospital Clinical Research Funding(No.2022-PUMCH-D-002).
评论